FPMI Restructures CardioPET License With Massachusetts General Hospital
27. September 2018 09:00 ET
|
FluoroPharma Medical, Inc.
MONTCLAIR, NJ, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that it has reached an agreement with The General Hospital Corporation,...
FluoroPharma Announces Closing of Stock Buyback Transaction
10. Januar 2018 17:06 ET
|
FluoroPharma Medical, Inc.
Montclair, NJ , Jan. 10, 2018 (GLOBE NEWSWIRE) -- FluoroPharma Medical Inc. (OTCQB: FPMI) today announced it completed the buyback of convertible preferred and common shares held by Platinum Long...
FluoroPharma Announces the Promotion of Tamara Rhein to CFO
22. August 2012 13:22 ET
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
FluoroPharma Announces Milestone for BFPET
26. Juli 2012 13:23 ET
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., July 26, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
18. Juni 2012 09:00 ET
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., June 18, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough molecular imaging products that utilize positron...
Thijs Spoor Appointed Chairman of the Board of FluoroPharma Medical, Inc.
15. Juni 2012 16:12 ET
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., June 15, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
LifeTech Capital Initiates Coverage of FluoroPharma Medical, Inc.
31. Mai 2012 14:49 ET
|
FluoroPharma Medical, Inc.
BOSTON, May 31, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission...
FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position
19. März 2012 10:12 ET
|
FluoroPharma Medical, Inc.
BOSTON, March 19, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI) today announces that BFPET, its imaging agent for measuring cardiovascular blood flow, has been granted patent rights...
FluoroPharma Medical Announces Phase II Study for CardioPET
01. März 2012 10:15 ET
|
FluoroPharma Medical, Inc.
BOSTON, March 1, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission...
FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
13. Januar 2012 10:54 ET
|
FluoroPharma Medical, Inc.
BOSTON, Jan. 13, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, today announced...